If true, this suggests that neuroendocrine tumors that produce one or more RSPOs and Lgr4/5/6 would not downregulate Sstr2 expression, even if they are expressing significant levels of Wnt ligands. Here, SSTR2 is linked to neuroendocrine neoplasm.